1. New Product Review (September 2003). Norelgestromin/ethinyl oestradiol transdermal contraceptive system (Evra). J Fam Plann Reprod Health Care. Jan 2004;30(1):43-45.
Link to PubMed
2. Contraceptive Patch Labeling Updated. Nurse Pract. Jan 2006;31(1):72.
Link to PubMed
3. Thacker HL, Falcone T, Atreja A, Jain A, Harris CM. How should we advise patients about the contraceptive patch, given the FDA warning? Cleve Clin J Med. Jan 2006;73(1):45-47.
Link to PDF
4. Wooltorton E. The Evra (ethinyl estradiol/norelgestromin) contraceptive patch: estrogen exposure concerns. Cmaj. Jan 17 2006;174(2):164-165.
Link to PDF
